Objective: To determine if women receiving intrauterine devices (IUCDs) out
side of menses have an acceptable rate of insertion problems and subsequent
IUCD-related complications.
Design: Cross-sectional and prospective cohort study of insertions at times
other than during menses.
Setting: The study was carried out in two government family planning (FP) c
linics in Nairobi, Kenya.
Subjects: After appropriate pre-test and post-test HIV counselling, 1686 wo
men requesting IUCDs at two FP clinics between 1994 and 1995 in Nairobi wer
e enrolled at baseline into a study examining the effect of human immune-de
ficiency virus (HIV) infection on IUCD-related complications. Six hundred a
nd forty nine women (156 HIV-infected and 493 HIV-uninfected) were selected
for the four month follow up study. They were classified according to thei
r menstrual cycle status at time of IUCD insertion.
Main outcome measures: Problems at the time of insertion (pain, bleeding, i
mmediate expulsion) and IUCD-related complications through four months.
Results: Rates of immediate insertion problems were low in the women who ha
d insertions during menses (7.0%), outside Of menses (4.0%) or had oligomen
orrhea/amenorrhea (2.6%), The adjusted odds ratios for IUCD insertion probl
ems outside of menses and in oligomenorrhea/amenorrhea (versus women with i
nsertion during menses) were 0.54 (95% CI 0.18-1.59) and 0.39 (95% CI 0.12-
1.29) respectively. IUCD-related complications were higher in the oligomeno
rrhea/amenorrhea (11.5%) or insertion outside of menses (6.9%), than the wi
thin menses (4.3%) groups. However, the differences were not statistically
significant, Adjusted odds ratios for IUCD outside of menses and oligomenor
rhoea/amenorrhea groups were 1.65 (95% CI 0.21-12.91) and 2.72 (95% CI 0.33
-21.71) respectively.
Conclusion: The results confirm that the IUCD can be safely inserted outsid
e of menses with minimal insertion difficulties and subsequent complication
s. Availability of IUCDs outside of menses may enhance IUCD acceptance in K
enya and create better opportunity for visual screening of the cervix for s
exually transmitted infections.